ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests
ACOG2022
ACOG — 2022
SMFM supports the new ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests and continues to support existing SMFM guidance on NIPT.
This is a statement from Christopher Zahn, MD, chief of Clinical Practice and interim chief of Health Equity and Quality for the American College of Obstetricians and Gynecologists (ACOG)
SMFM supports the new ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests and continues to support existing SMFM guidance on NIPT.
This is a statement from Christopher Zahn, MD, chief of Clinical Practice and interim chief of Health Equity and Quality for the American College of Obstetricians and Gynecologists (ACOG)